{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:07:42Z","timestamp":1792667262079,"version":"4.5.0"},"reference-count":154,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","award":["NO.F.30\\u2013583\/2021"],"award-info":[{"award-number":["NO.F.30\\u2013583\/2021"]}],"id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016045","name":"University of Central Punjab","doi-asserted-by":"publisher","award":["CUPB\/CC\/PF\/20\/226"],"award-info":[{"award-number":["CUPB\/CC\/PF\/20\/226"]}],"id":[{"id":"10.13039\/100016045","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["IF210098"],"award-info":[{"award-number":["IF210098"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine &amp; Growth Factor Reviews"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.cytogfr.2026.01.001","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:22:04Z","timestamp":1767658924000},"page":"1-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Cytokine associated neuroinflammation in Parkinson\u2019s disease: Molecular pathways, therapeutic targets, and translational insights"],"prefix":"10.1016","volume":"88","author":[{"given":"Rishika","family":"Dhapola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sneha","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prajjwal","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohit","family":"Paidlewar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balachandar","family":"Vellingiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bikash","family":"Medhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2616-0195","authenticated-orcid":false,"given":"Dibbanti","family":"HariKrishnaReddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cytogfr.2026.01.001_bib1","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson\u2019s disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.cytogfr.2026.01.001_bib2","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","article-title":"The pathogenesis of Parkinson\u2019s disease","volume":"403","author":"Morris","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.cytogfr.2026.01.001_bib3","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","article-title":"Challenges in the diagnosis of Parkinson\u2019s disease","volume":"20","author":"Tolosa","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib4","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1007\/s11064-023-03904-0","article-title":"Mitochondrial dysfunction and Parkinson\u2019s disease: pathogenesis and therapeutic strategies","volume":"48","author":"Moradi Vastegani","year":"2023","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib5","doi-asserted-by":"crossref","first-page":"20220063","DOI":"10.1042\/NS20220063","article-title":"Cytokine activity in Parkinson\u2019s disease","volume":"7","author":"Dzamk","year":"2023","journal-title":"Neuron Signal"},{"key":"10.1016\/j.cytogfr.2026.01.001_bib6","article-title":"The role of inflammation in hematopoiesis and bone marrow failure: what can we learn from mouse models?","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib7","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1089\/wound.2021.0065","article-title":"Hematopoietic stem cells in wound healing response","volume":"11","author":"Urao","year":"2022","journal-title":"Adv. Wound Care"},{"key":"10.1016\/j.cytogfr.2026.01.001_bib8","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.3390\/cells10061386","article-title":"Inflammation, aging and hematopoiesis: a complex relationship","volume":"10","author":"Bousounis","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.cytogfr.2026.01.001_bib9","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3390\/ijms24010641","article-title":"Acute inflammation in tissue healing","volume":"24","author":"Soliman","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib10","unstructured":"M.J. Cameron, D.J. Kelvin, Cytokines, Chemokines and Their Receptors, in: Landes Biosci., Landes Bioscience, 2013. \u3008https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK6294\/\u3009 (accessed August 28, 2025)."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib11","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.3390\/cells11182908","article-title":"Neuroinflammation and Parkinson\u2019s disease\u2014from neurodegeneration to therapeutic Opportunities","volume":"11","author":"Ara\u00fajo","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.cytogfr.2026.01.001_bib12","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4274\/balkanmedj.galenos.2022.2022-7-100","article-title":"Neuroinflammation in Parkinson\u2019s disease and its treatment opportunities","volume":"39","author":"\u00c7\u0131nar","year":"2022","journal-title":"Balk. Med. J."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib13","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s11910-022-01207-5","article-title":"Neurodegeneration and neuroinflammation in Parkinson\u2019s disease: a self-sustained loop","volume":"22","author":"Arena","year":"2022","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.666737","article-title":"The pathogenesis of Parkinson\u2019s Disease: a complex interplay between astrocytes, microglia, and T lymphocytes?","volume":"12","author":"MacMahon Copas","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib15","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1172\/JCI90609","article-title":"CNS inflammation and neurodegeneration","volume":"127","author":"Chitnis","year":"2017","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.cytogfr.2026.01.001_bib16","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1093\/brain\/awaa246","article-title":"Mitochondrial damage-associated inflammation highlights biomarkers in PRKN\/PINK1 parkinsonism","volume":"143","author":"Borsche","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.cytogfr.2026.01.001_bib17","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00401-021-02268-5","article-title":"Periphery and brain, innate and adaptive immunity in Parkinson\u2019s disease","volume":"141","author":"Harms","year":"2021","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib18","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.3390\/cells12071012","article-title":"Microglia mediated neuroinflammation in Parkinson\u2019s Disease","volume":"12","author":"Isik","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.cytogfr.2026.01.001_bib19","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3390\/ph18010104","article-title":"Targeting cytokine-mediated inflammation in brain disorders: developing new treatment strategies","volume":"18","author":"Mallick","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.cytogfr.2026.01.001_bib20","first-page":"199","article-title":"Berberine neuroprotection and antioxidant activity","author":"Imenshahidi","year":"2020","journal-title":"Oxid. Stress Diet. Antioxid. Neurol. Dis."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib21","doi-asserted-by":"crossref","first-page":"999","DOI":"10.2174\/1381612053381620","article-title":"Inflammatory process in Parkinson\u2019s disease: role for cytokines","volume":"11","author":"Nagatsu","year":"2005","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib22","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.nbd.2014.08.011","article-title":"Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-\u03b3 agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson\u2019s disease","volume":"71","author":"Pisanu","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib23","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.expneurol.2010.08.016","article-title":"Antiparkinsonian trophic action of glial cell line-derived neurotrophic factor and transforming growth factor \u03b21 is enhanced after co-infusion in rats","volume":"226","author":"Gonzalez-Aparicio","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib24","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.3390\/cells12192336","article-title":"Astrocytes in Parkinson\u2019s disease: from role to possible intervention","volume":"12","author":"Wang","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.cytogfr.2026.01.001_bib25","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2026.01.001_bib26","doi-asserted-by":"crossref","first-page":"634","DOI":"10.3390\/brainsci13040634","article-title":"Microglia and astrocytes dysfunction and key neuroinflammation-based biomarkers in Parkinson\u2019s disease","volume":"13","author":"Chen","year":"2023","journal-title":"Brain Sci."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-023-39038-8","article-title":"The contribution of inflammatory astrocytes to BBB impairments in a brain-chip model of Parkinson\u2019s disease","volume":"14","author":"de Rus Jacquet","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib28","first-page":"1","article-title":"A systematic review and meta-analysis of inflammatory biomarkers in Parkinson\u2019s disease","volume":"9","author":"Qu","year":"2023","journal-title":"Npj Park. Dis."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib29","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.163359","article-title":"Blocking IL-6 signaling prevents astrocyte-induced neurodegeneration in an iPSC-based model of Parkinson\u2019s disease","volume":"9","author":"Pons-Espinal","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.cytogfr.2026.01.001_bib30","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1080\/01616412.2021.2024726","article-title":"Dopaminergic neuronal death in the substantia nigra associates with change in serum levels of TNF-\u03b1 and IL-1\u03b2; evidence from early experimental model of Parkinson\u2019s disease","volume":"44","author":"Piri","year":"2022","journal-title":"Neurol. Res."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib31","first-page":"2117","article-title":"Role of NLRP3 Inflammasome in Parkinson\u2019s disease and therapeutic considerations","volume":"12","author":"Nguyen","year":"2022","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2023.578222","article-title":"Plasma TNF-\u03b1 and phosphorylated \u03b1-syn are associated with fatigue in patients with Parkinson\u2019s disease","volume":"385","author":"Wang","year":"2023","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.617085","article-title":"Contributive role of TNF-\u03b1 to L-DOPA-induced dyskinesia in a unilateral 6-OHDA lesion model of Parkinson\u2019s disease","volume":"11","author":"dos Santos Pereira","year":"2021","journal-title":"Front. Pharm."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib34","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3390\/cells14080600","article-title":"Therapeutic potential of mesenchymal stem cell-derived extracellular vesicles in the treatment of Parkinson\u2019s disease","volume":"14","author":"Volarevic","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.cytogfr.2026.01.001_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105805","article-title":"The promise of the TGF-\u03b2 superfamily as a therapeutic target for Parkinson\u2019s disease","volume":"171","author":"Karampetsou","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib36","doi-asserted-by":"crossref","first-page":"7741","DOI":"10.3390\/ijms25147741","article-title":"Exploring fecal microbiota transplantation for modulating inflammation in Parkinson\u2019s Disease: A Review of Inflammatory Markers and Potential effects","volume":"25","author":"Sadowski","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2025.165968","article-title":"Resveratrol-integrated Se-chitosan nanogel for protein corona-mediated blood-brain barrier traversing and anti-inflammatory treatment for Parkinson\u2019s disease","volume":"520","author":"Cao","year":"2025","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib38","first-page":"S183","article-title":"Blood and Cerebrospinal Fluid Biomarkers of Inflammation in Parkinson\u2019s disease","volume":"12","author":"Zimmermann","year":"2022","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib39","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1080\/00207454.2023.2292951","article-title":"Plasma cytokines profile in patients with Alzheimer\u2019s and Parkinson\u2019s disease: a comparative study in terms of inflammation","volume":"135","author":"Shateri","year":"2025","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib40","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.154804","article-title":"MCP-1\/CCR2 axis inhibition sensitizes the brain microenvironment against melanoma brain metastasis progression","volume":"7","author":"Pozzi","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.cytogfr.2026.01.001_bib41","doi-asserted-by":"crossref","first-page":"959","DOI":"10.3390\/ijms26030959","article-title":"CX3CL1 Regulation of Gliosis in Neuroinflammatory and Neuroprotective Processes","volume":"26","author":"Guti\u00e9rrez","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-019-1646-6","article-title":"CXCL12 is involved in \u03b1-synuclein-triggered neuroinflammation of Parkinson\u2019s disease","volume":"16","author":"Li","year":"2019","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib43","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.4103\/1673-5374.215250","article-title":"Interleukin 4-induced neuroprotection and regulation of microglia activation as a therapeutic approach in the MPTP model of parkinson\u2019s disease","volume":"12","author":"Spittau","year":"2017","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib44","doi-asserted-by":"crossref","first-page":"309","DOI":"10.5607\/en.2018.27.4.309","article-title":"Interleukin-4 contributes to degeneration of dopamine neurons in the lipopolysaccharide-treated substantia nigra in vivo","volume":"27","author":"Bok","year":"2018","journal-title":"Exp. Neurobiol."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib45","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2011.17","article-title":"IFN-\u03b3 signaling, with the synergistic contribution of TNF-\u03b1, mediates cell specific microglial and astroglial activation in experimental models of Parkinson\u2019s disease","volume":"2","author":"Barcia","year":"2011","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib46","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/imr.13092","article-title":"Unique aspects of IFN-\u03b3\/STAT1 signaling in neurons","volume":"311","author":"Clark","year":"2022","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2025.111273","article-title":"IL-2\/anti-IL-2 complexes attenuates neuroinflammation and neurodegeneration in mice of experimental Parkinson\u2019s disease","volume":"223","author":"Li","year":"2025","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib48","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.neulet.2008.06.040","article-title":"Serum interleukin (IL-2, IL-10, IL-6, IL-4), TNF\u03b1, and INF\u03b3 concentrations are elevated in patients with atypical and idiopathic parkinsonism","volume":"441","author":"Brodacki","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib49","doi-asserted-by":"crossref","DOI":"10.1155\/2024\/9069870","article-title":"Assessing the causal relationship between genetically determined inflammatory cytokines and Parkinson\u2019s Disease Risk: a bidirectional two-sample mendelian randomization study","volume":"2024","author":"Xue","year":"2024","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib50","doi-asserted-by":"crossref","first-page":"1250685","DOI":"10.3389\/fnagi.2023.1250685","article-title":"CCL5 promotes LFA-1 expression in Th17 cells and induces LCK and ZAP70 activation in a mouse model of Parkinson\u2019s disease","volume":"15","author":"Zhao","year":"2023","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135776","article-title":"Dopaminergic Toxin 1-Methyl-4-Phenylpyridinium, Proteins \u03b1-Synuclein and Glia Maturation Factor Activate Mast Cells and Release Inflammatory Mediators","volume":"10","author":"Kempuraj","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cytogfr.2026.01.001_bib52","first-page":"461","article-title":"The role of oxidative stress in Parkinson\u2019s disease","volume":"3","author":"Dias","year":"2013","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib53","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nri1312","article-title":"NOX enzymes and the biology of reactive oxygen","volume":"4","author":"Lambeth","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117177","article-title":"The interplay between cytokines, inflammation, and antioxidants: mechanistic insights and therapeutic potentials of various antioxidants and anti-cytokine compounds","volume":"178","author":"Bhol","year":"2024","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib55","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.apsb.2024.10.004","article-title":"Oxidative stress and inflammation in the pathogenesis of neurological disorders: mechanisms and implications","volume":"15","author":"Dash","year":"2025","journal-title":"Acta Pharm. Sin. B."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.585584","article-title":"Molecular mechanisms of glutamate Toxicity in Parkinson\u2019s disease","volume":"14","author":"Wang","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib57","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jphs.2020.07.011","article-title":"Glutamate-induced excitotoxicity in Parkinson\u2019s disease: the role of glial cells","volume":"144","author":"Iovino","year":"2020","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib58","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/npp.2016.199","article-title":"Inflammation, glutamate, and glia: a trio of trouble in mood disorders","volume":"42","author":"Haroon","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.cytogfr.2026.01.001_bib59","doi-asserted-by":"crossref","first-page":"65","DOI":"10.4103\/sni.sni_441_16","article-title":"Parkinson\u2019s disease: microglial\/macrophage-induced immunoexcitotoxicity as a central mechanism of neurodegeneration","volume":"8","author":"Blaylock","year":"2017","journal-title":"Surg. Neurol. Int."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib60","article-title":"Inflammatory Mechanisms of Neurodegeneration in Toxin-Based Models of Parkinson\u2032s Disease","volume":"2011","author":"Litteljohn","year":"2011","journal-title":"Park. Dis."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib61","article-title":"The involvement of neuroinflammation and kynurenine pathway in Parkinson\u2032s disease","volume":"2011","author":"Zinger","year":"2011","journal-title":"Park. Dis."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib62","doi-asserted-by":"crossref","first-page":"45663","DOI":"10.1021\/acsomega.4c06546","article-title":"The impact of the blood\u2212brain barrier and its dysfunction in Parkinson\u2019s Disease: contributions to Pathogenesis and Progression","volume":"9","author":"Khalid","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.cytogfr.2026.01.001_bib63","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/cns.13569","article-title":"Peripheral inflammation and blood\u2013brain barrier disruption: effects and mechanisms","volume":"27","author":"Huang","year":"2021","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib64","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s40035-024-00430-z","article-title":"Blood\u2013brain barrier alterations and their impact on Parkinson\u2019s disease pathogenesis and therapy","volume":"13","author":"Lau","year":"2024","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib65","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.expneurol.2016.09.003","article-title":"\u03b1-Synuclein pre-formed fibrils impair tight junction protein expression without affecting cerebral endothelial cell function","volume":"285","author":"Kuan","year":"2016","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40035-015-0042-0","article-title":"Neuroinflammation in Parkinson\u2019s disease and its potential as therapeutic target","volume":"4","author":"Wang","year":"2015","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib67","doi-asserted-by":"crossref","first-page":"1013933","DOI":"10.3389\/fnmol.2022.1013933","article-title":"New insight into neurological degeneration: Inflammatory cytokines and blood\u2013brain barrier","volume":"15","author":"Yang","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib68","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","article-title":"Transneuronal propagation of pathologic \u03b1-synuclein from the gut to the brain models Parkinson\u2019s disease","volume":"103","author":"Kim","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.cytogfr.2026.01.001_bib69","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00401-014-1343-6","article-title":"Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats","volume":"128","author":"Holmqvist","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib70","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","article-title":"Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson\u2019s disease","volume":"167","author":"Sampson","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.cytogfr.2026.01.001_bib71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-019-1528-y","article-title":"Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson\u2019s disease","volume":"16","author":"Lin","year":"2019","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib72","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/mds.26069","article-title":"Gut microbiota are related to Parkinson\u2019s disease and clinical phenotype","volume":"30","author":"Scheperjans","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib73","first-page":"93","article-title":"Parkinson\u2019s Disease, it takes guts: The correlation between intestinal microbiome and cytokine network with neurodegeneration","volume":"12","author":"Xiromerisiou","year":"2023","journal-title":"Biol. (Basel)"},{"key":"10.1016\/j.cytogfr.2026.01.001_bib74","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2019.00992","article-title":"Fecal calprotectin as a marker of the gut immune system activation is elevated in parkinson\u2019s disease","volume":"13","author":"Mulak","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib75","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.parkreldis.2018.02.022","article-title":"Fecal markers of intestinal inflammation and intestinal permeability are elevated in Parkinson\u2019s disease","volume":"50","author":"Schwiertz","year":"2018","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-021-00427-6","article-title":"Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson\u2019s disease","volume":"16","author":"Aho","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib77","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2015.00032","article-title":"Is dysregulation of the HPA-axis a core pathophysiology mediating co-morbid depression in neurodegenerative diseases?","volume":"6","author":"Du","year":"2015","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.cytogfr.2026.01.001_bib78","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1159\/000343808","article-title":"Diurnal variation of hypothalamic function and chronic subthalamic nucleus stimulation in Parkinson\u2019s disease","volume":"97","author":"Seifried","year":"2013","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.cytogfr.2026.01.001_bib79","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1136\/bmjdrc-2022-003218","article-title":"Review of the direct and indirect effects of hyperglycemia on the HPA axis in T2DM and the co-occurrence of depression","volume":"12","author":"Mosili","year":"2024","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"10.1016\/j.cytogfr.2026.01.001_bib80","doi-asserted-by":"crossref","DOI":"10.3389\/fnana.2015.00032","article-title":"Inflammation in Parkinson\u2019s disease: Role of glucocorticoids","volume":"9","author":"Herrero","year":"2015","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib81","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1089\/vim.2005.18.41","article-title":"Immune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral Infection","volume":"18","author":"Silverman","year":"2005","journal-title":"Viral Immunol."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib82","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0092-8674(94)90408-1","article-title":"Identification and cloning of ELF-1, a developmentally expressed ligand for the Mek4 and Sek receptor tyrosine kinases","volume":"79","author":"Cheng","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.cytogfr.2026.01.001_bib83","first-page":"97","article-title":"Identification of alternatively spliced mRNAs encoding variants of MDK1, a novel receptor tyrosine kinase expressed in the murine nervous system","volume":"10","author":"Ciossek","year":"1995","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2026.01.001_bib84","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1007\/s10571-023-01390-0","article-title":"Unraveling the potential of EphA4: a breakthrough target and beacon of hope for neurological diseases","volume":"43","author":"Verma","year":"2023","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib85","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s12035-020-02122-x","article-title":"EphA1 activation induces neuropathological changes in a mouse model of Parkinson\u2019s disease through the CXCL12\/CXCR4 signaling pathway","volume":"58","author":"Ma","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib86","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1182\/blood-2016-04-709519","article-title":"Ibrutinib inhibits CD20 upregulation on CLL B cells mediated by the CXCR4\/SDF-1 axis","volume":"128","author":"Pavlasova","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2026.01.001_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnrt.2022.100040","article-title":"Roles of Eph\/ephrin signaling pathway in repair and regeneration for ischemic cerebrovascular and cardiovascular diseases","volume":"11","author":"Zheng","year":"2023","journal-title":"J. Neurorestoratology"},{"key":"10.1016\/j.cytogfr.2026.01.001_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s11658-022-00311-1","article-title":"The roles of Eph receptors, neuropilin-1, P2X7, and CD147 in COVID-19-associated neurodegenerative diseases: inflammasome and JaK inhibitors as potential promising therapies","volume":"27","author":"Zalpoor","year":"2022","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114902","article-title":"cGAS-STING and neurodegenerative diseases: a molecular crosstalk and therapeutic perspective","volume":"159","author":"Dhapola","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib90","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.4103\/NRR.NRR-D-23-01684","article-title":"The cGAS-STING-interferon regulatory factor 7 pathway regulates neuroinflammation in Parkinson\u2019s disease","volume":"20","author":"Zhou","year":"2025","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-021-02983-5","article-title":"SARS-CoV-2 infection induces a pro-inflammatory cytokine response through cGAS-STING and NF-\u03baB","volume":"5","author":"Neufeldt","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib92","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/s41577-021-00524-z","article-title":"The cGAS\u2013STING pathway as a therapeutic target in inflammatory diseases","volume":"21","author":"Decout","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109977","article-title":"TNF leads to mtDNA release and cGAS\/STING-dependent interferon responses that support inflammatory arthritis","volume":"37","author":"Willemsen","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib94","first-page":"1","article-title":"Rhapontigenin attenuates neurodegeneration in a parkinson\u2019s disease model by downregulating mtDNA-cGAS-STING-NF-\u03baB-mediated neuroinflammation via PINK1\/DRP1-dependent microglial mitophagy","volume":"82","author":"Zhang","year":"2025","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00018-025-05873-9","article-title":"Rhapontigenin attenuates neurodegeneration in a parkinson\u2019s disease model by downregulating mtDNA-cGAS-STING-NF-\u03baB-mediated neuroinflammation via PINK1\/DRP1-dependent microglial mitophagy","volume":"82","author":"Su","year":"2025","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbi.2025.106065","article-title":"Crosstalk between DNA damage and cGAS-STING immune pathway drives neuroinflammation and dopaminergic neurodegeneration in Parkinson\u2019s disease","volume":"130","author":"Khan","year":"2025","journal-title":"Brain. Behav. Immun."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib97","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1242\/dev.121.4.1053","article-title":"Identifying tumor suppressors in genetic mosaics: the Drosophila lats gene encodes a putative protein kinase","volume":"121","author":"Xu","year":"1995","journal-title":"Development"},{"key":"10.1016\/j.cytogfr.2026.01.001_bib98","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/jnr.24551","article-title":"The emerging role of Hippo signaling in neurodegeneration","volume":"98","author":"Sahu","year":"2020","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib99","article-title":"The Crosstalk Between Hippo-YAP Pathway and Innate Immunity","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib100","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/jnc.15579","article-title":"The netrin-1 receptor DCC promotes the survival of a subpopulation of midbrain dopaminergic neurons: relevance for ageing and Parkinson\u2019s disease","volume":"161","author":"Lo","year":"2022","journal-title":"J. Neurochem."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114619","article-title":"An update on the role of Hippo signaling pathway in ischemia-associated central nervous system diseases","volume":"162","author":"Wei","year":"2023","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib102","doi-asserted-by":"crossref","first-page":"5222","DOI":"10.3390\/ijms24065222","article-title":"Limonene, a monoterpene, mitigates rotenone-induced dopaminergic neurodegeneration by modulating neuroinflammation, hippo signaling and apoptosis in rats","volume":"24","author":"Eddin","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-020-03229-8","article-title":"The role of the Hippo pathway in the pathogenesis of inflammatory bowel disease","volume":"12","author":"Xie","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib104","doi-asserted-by":"crossref","first-page":"15002","DOI":"10.1074\/jbc.M117.804005","article-title":"Palmitic acid dysregulates the Hippo-YAP pathway and inhibits angiogenesis by inducing mitochondrial damage and activating the cytosolic DNA sensor cGAS-STING-IRF3 signaling mechanism","volume":"292","author":"Yuan","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2022.157134","article-title":"Melatonin attenuates manganese-induced mitochondrial fragmentation by suppressing the Mst1\/JNK signaling pathway in primary mouse neurons","volume":"844","author":"Liu","year":"2022","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib106","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/jcp.29070","article-title":"Proinflammation effect of Mst1 promotes BV-2 cell death via augmenting Drp1-mediated mitochondrial fragmentation and activating the JNK pathway","volume":"235","author":"Tian","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib107","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1093\/hmg\/ddad115","article-title":"JMJD3 and SNAI2 synergistically protect against Parkinson\u2019s disease by mediating the YAP\/HIF1\u03b1 signaling pathway in a mouse model","volume":"32","author":"Dong","year":"2023","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.cytogfr.2026.01.001_bib108","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/s41423-018-0007-1","article-title":"Role of Hippo signaling in regulating immunity","volume":"15","author":"Hong","year":"2018","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib109","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s13770-024-00635-3","article-title":"Human nasal inferior turbinate-derived neural stem cells improve the niche of substantia nigra par compacta in a Parkinson\u2019s disease model by modulating hippo signaling","volume":"21","author":"Choi","year":"2024","journal-title":"Tissue Eng. Regen. Med."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.109974","article-title":"Celastrol inhibits necroptosis by attenuating the RIPK1\/RIPK3\/MLKL pathway and confers protection against acute pancreatitis in mice","volume":"117","author":"Liang","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib111","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3390\/cells12030417","article-title":"RIPK1 Regulates Microglial Activation in Lipopolysaccharide-Induced Neuroinflammation and MPTP-Induced Parkinson\u2019s Disease Mouse Models","volume":"12","author":"Kim","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.cytogfr.2026.01.001_bib112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11064-025-04448-1","article-title":"From RIPK1 to Necroptosis: Pathogenic Mechanisms in Neurodegenerative Diseases","volume":"50","author":"Kang","year":"2025","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib113","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41583-018-0093-1","article-title":"Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases","volume":"20","author":"Yuan","year":"2019","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib114","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3390\/brainsci13050733","article-title":"RIPK1-Induced A1 Reactive Astrocytes in Brain in MPTP-Treated Murine Model of Parkinson\u2019s disease","volume":"13","author":"Qiao","year":"2023","journal-title":"Brain Sci."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib115","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/01480545.2021.2008127","article-title":"Preventive treatment with sodium para-aminosalicylic acid inhibits manganese-induced apoptosis and inflammation via the MAPK pathway in rat thalamus","volume":"46","author":"Deng","year":"2023","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib116","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.neuroscience.2012.02.001","article-title":"Parkinson\u2019s disease-linked leucine-rich repeat kinase 2(R1441G) mutation increases proinflammatory cytokine release from activated primary microglial cells and resultant neurotoxicity","volume":"208","author":"Gillardon","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.cytogfr.2026.01.001_bib117","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00702-011-0653-2","article-title":"Parkinson\u2019s disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structures","volume":"118","author":"Hakimi","year":"2011","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib118","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s13238-016-0326-x","article-title":"LRRK2 enhances Nod1\/2-mediated inflammatory cytokine production by promoting Rip2 phosphorylation","volume":"8","author":"Yan","year":"2017","journal-title":"Protein Cell"},{"key":"10.1016\/j.cytogfr.2026.01.001_bib119","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1042\/BST20180463","article-title":"LRRK2 regulation of immune-pathways and inflammatory disease","volume":"47","author":"Wallings","year":"2019","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib120","first-page":"1","article-title":"Effect of LRRK2 protein and activity on stimulated cytokines in human monocytes and macrophages","volume":"8","author":"Ahmadi Rastegar","year":"2022","journal-title":"Npj Park. Dis."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib121","first-page":"1","article-title":"Mutant LRRK2 in lymphocytes regulates neurodegeneration via IL-6 in an inflammatory model of Parkinson\u2019s disease","volume":"8","author":"Kozina","year":"2022","journal-title":"Npj Park. Dis."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib122","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s40478-016-0396-2","article-title":"LRRK2 contributes to monocyte dysregulation in Parkinson\u2019s disease","volume":"4","author":"Bliederhaeuser","year":"2016","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib123","first-page":"1","article-title":"LRRK2 levels in immune cells are increased in Parkinson\u2019s disease","volume":"3","author":"Cook","year":"2017","journal-title":"Npj Park. Dis."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib124","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.bbrc.2012.03.088","article-title":"Sirtuin inhibition attenuates the production of inflammatory cytokines in lipopolysaccharide-stimulated macrophages","volume":"420","author":"Fernandes","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib125","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s11064-022-03560-w","article-title":"Mitochondrial Sirtuins in Parkinson\u2019s Disease","volume":"47","author":"He","year":"2022","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib126","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.14336\/AD.2020.0216","article-title":"The critical role of sirt1 in parkinson\u2019s disease: mechanism and therapeutic considerations","volume":"11","author":"Li","year":"2020","journal-title":"Aging Dis."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib127","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032019","article-title":"Ephrin-A1-mediated dopaminergic neurogenesis and Angiogenesis in a Rat Model of Parkinson\u2019s disease","volume":"7","author":"Jing","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cytogfr.2026.01.001_bib128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43094-025-00831-5","article-title":"6-Paradol mitigates rotenone-induced Parkinson\u2019s disease via shutting TNFR-1\/RIPK1\/RIPK3\/MLKL cascade and enhancement of PPAR\u03b3\/PGC-1\u03b1\/TFAM axis","volume":"11","author":"Sirwi","year":"2025","journal-title":"Futur. J. Pharm. Sci."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib129","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.3390\/cells12131799","article-title":"LRRK2 kinase inhibition attenuates neuroinflammation and cytotoxicity in animal models of Alzheimer\u2019s and Parkinson\u2019s disease-related neuroinflammation","volume":"12","author":"Mutti","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.cytogfr.2026.01.001_bib130","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.2147\/JIR.S317672","article-title":"Melatonin attenuates neuroinflammation by down-regulating nlrp3 inflammasome via a sirt1-dependent pathway in mptp-induced models of parkinson\u2019s disease","volume":"14","author":"Zheng","year":"2021","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib131","doi-asserted-by":"crossref","first-page":"7159","DOI":"10.3390\/molecules27217159","article-title":"Europinidin Inhibits Rotenone-Activated Parkinson\u2019s disease in rodents by decreasing lipid peroxidation and inflammatory cytokines pathways","volume":"27","author":"Altharawi","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.cytogfr.2026.01.001_bib132","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.3390\/cells11213468","article-title":"Rifaximin modifies gut microbiota and attenuates inflammation in Parkinson\u2019s disease: preclinical and clinical studies","volume":"11","author":"Hong","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.cytogfr.2026.01.001_bib133","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1615\/JEnvironPatholToxicolOncol.v40.i1.70","article-title":"Tomentosin reduces behavior deficits and neuroinflammatory response in MPTP-induced Parkinson\u2019s disease in mice","volume":"40","author":"Fan","year":"2021","journal-title":"J. Environ. Pathol. Toxicol. Oncol."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2025.e00690","article-title":"Montelukast alleviates neuroinflammation and improves motor functions in the line 61 model of Parkinson\u2019s disease: an exploratory study","author":"Strempfl","year":"2025","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.cytogfr.2026.01.001_bib135","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1007\/s12035-020-01940-3","article-title":"Hesperidin ameliorates anxiety-depressive-like behavior in 6-OHDA model of Parkinson\u2019s disease by regulating striatal cytokine and neurotrophic factors levels and dopaminergic innervation loss in the striatum of mice","volume":"57","author":"Antunes","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib136","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s11481-016-9720-7","article-title":"Vitamin D Treatment Attenuates Neuroinflammation and Dopaminergic Neurodegeneration in an Animal Model of Parkinson\u2019s Disease, Shifting M1 to M2 Microglia Responses","volume":"12","author":"Calvello","year":"2017","journal-title":"J. Neuroimmune Pharm."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib137","article-title":"Probing gut-brain links in Alzheimer\u2019s disease with rifaximin","volume":"8","author":"Suhocki","year":"2022","journal-title":"Alzheimer\u2019S. Dement. Transl. Res. Clin. Inter."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib138","doi-asserted-by":"crossref","first-page":"11","DOI":"10.37757\/MR2012V14.N1.4","article-title":"Use of Cuban recombinant human erythropoietin in Parkinson\u2019s disease treatment","volume":"14","author":"Pedroso","year":"2012","journal-title":"MEDICC Rev."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib139","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.neuroscience.2011.05.018","article-title":"Erythropoietin promotes survival and regeneration of insect neurons in vivo and in vitro","volume":"188","author":"Ostrowski","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.cytogfr.2026.01.001_bib140","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.3390\/brainsci14111147","article-title":"The impact of probiotics on clinical symptoms and peripheral cytokines levels in Parkinson\u2019s disease: preliminary in Vivo data","volume":"14","author":"Magistrelli","year":"2024","journal-title":"Brain Sci."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib141","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1080\/07315724.2017.1347074","article-title":"The effects of probiotic supplementation on gene expression related to inflammation, insulin, and lipids in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled trial","volume":"36","author":"Tamtaji","year":"2017","journal-title":"J. Am. Coll. Nutr."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib142","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1080\/00207454.2021.1910259","article-title":"G-CSF reduces loss of dopaminergic neurons by inhibiting TNF-\u03b1 and IL-1\u03b2 in mouse model of Parkinson\u2019s disease","volume":"133","author":"Zhang","year":"2023","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib143","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1755-5949.2008.00055.x","article-title":"Niacin for stroke prevention: evidence and rationale","volume":"14","author":"Keener","year":"2008","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib144","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/nu13010028","article-title":"Niacin and Butyrate: nutraceuticals targeting dysbiosis and intestinal permeability in Parkinson\u2019s disease","volume":"13","author":"Karunaratne","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.cytogfr.2026.01.001_bib145","doi-asserted-by":"crossref","DOI":"10.1002\/mds.70028","article-title":"Allogeneic bone marrow-derived mesenchymal stem cells for Parkinson\u2019s disease: a randomized trial","author":"Schiess","year":"2025","journal-title":"Mov. Disord."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib146","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1002\/mds.28582","article-title":"Allogeneic bone marrow\u2013derived mesenchymal stem cell safety in idiopathic Parkinson\u2019s disease","volume":"36","author":"Schiess","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib147","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-025-93737-4","article-title":"Biofilm proficient Bacillus subtilis prevents neurodegeneration in Caenorhabditis elegans Parkinson\u2019s disease models via PMK-1\/p38 MAPK and SKN-1\/Nrf2 signaling","volume":"15","author":"Francisco","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib148","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00564","article-title":"Effect of bacillus subtilis strains on intestinal barrier function and inflammatory response","volume":"10","author":"Rhayat","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib149","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.3390\/ijms26073210","article-title":"The Role of \u03b17-nicotinic acetylcholine receptors in the pathophysiology and treatment of Parkinson\u2019s disease","volume":"26","author":"ElNebrisi","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib150","doi-asserted-by":"crossref","first-page":"763","DOI":"10.2174\/1874467214666210920104352","article-title":"A clinical perspective of soluble epoxide hydrolase inhibitors in metabolic and related cardiovascular diseases","volume":"15","author":"Verma","year":"2021","journal-title":"Curr. Mol. Pharm."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib151","doi-asserted-by":"crossref","DOI":"10.1111\/cts.70033","article-title":"Randomized, double-blind, phase 1a single-ascending dose and food effect studies assessing safety and pharmacokinetics of EC5026 in healthy volunteers","volume":"17","author":"Schmidt","year":"2024","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib152","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s11481-020-09943-6","article-title":"The potent PDE10A inhibitor MP-10 (PF-2545920) suppresses microglial activation in LPS-induced neuroinflammation and MPTP-induced Parkinson\u2019s disease mouse models","volume":"16","author":"Kim","year":"2021","journal-title":"J. Neuroimmune Pharm."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib153","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.999685","article-title":"A PDE10A inhibitor CPL500036 is a novel agent modulating striatal function devoid of most neuroleptic side-effects","volume":"13","author":"Matloka","year":"2022","journal-title":"Front. Pharm."},{"key":"10.1016\/j.cytogfr.2026.01.001_bib154","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182019","article-title":"The phosphodiesterase inhibitor, ibudilast, attenuates neuroinflammation in the MPTP model of Parkinson\u2019s disease","volume":"12","author":"Schwenkgrub","year":"2017","journal-title":"PLoS One"}],"container-title":["Cytokine &amp; Growth Factor Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610126000018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610126000018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T08:16:21Z","timestamp":1773994581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359610126000018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":154,"alternative-id":["S1359610126000018"],"URL":"https:\/\/doi.org\/10.1016\/j.cytogfr.2026.01.001","relation":{},"ISSN":["1359-6101"],"issn-type":[{"value":"1359-6101","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytokine associated neuroinflammation in Parkinson\u2019s disease: Molecular pathways, therapeutic targets, and translational insights","name":"articletitle","label":"Article Title"},{"value":"Cytokine & Growth Factor Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cytogfr.2026.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}